- Home
- IRON
IRON
Disc Medicine Inc.
as 07-26-2024 4:00pm EST
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | WATERTOWN |
| Market Cap: | 839.3M | IPO Year: | N/A |
| Target Price: | $63.50 | AVG Volume (30 days): | 368.3K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.60 - $77.60 | Next Earning Date: | 08-09-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Disc Medicine Inc. (IRON)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| White William Richard | IRON | Director | Jul 1 '24 | Sell | $46.45 | 74 | $3,437.20 | 0 | SEC Form 4 |
| White William Richard | IRON | Director | Jul 1 '24 | Sell | $45.92 | 109 | $5,004.83 | 74 | SEC Form 4 |
| White William Richard | IRON | Director | Jul 1 '24 | Sell | $45.07 | 18 | $811.27 | 183 | SEC Form 4 |
| ORBIMED ADVISORS LLC | IRON | Director | Jun 17 '24 | Buy | $36.00 | 10,986 | $395,496.00 | 235,391 | SEC Form 4 |
| ORBIMED ADVISORS LLC | IRON | Director | Jun 17 '24 | Buy | $36.00 | 43,944 | $1,581,984.00 | 941,569 | SEC Form 4 |
| ORBIMED ADVISORS LLC | IRON | Director | Jun 17 '24 | Buy | $36.00 | 28,404 | $1,022,544.00 | 608,611 | SEC Form 4 |
| Ashiya Mona | IRON | Director | Jun 17 '24 | Buy | $36.00 | 10,986 | $395,496.00 | 235,391 | SEC Form 4 |
| Ashiya Mona | IRON | Director | Jun 17 '24 | Buy | $36.00 | 43,944 | $1,581,984.00 | 941,569 | SEC Form 4 |
| Ashiya Mona | IRON | Director | Jun 17 '24 | Buy | $36.00 | 28,404 | $1,022,544.00 | 608,611 | SEC Form 4 |
| Bitterman Kevin | IRON | Director | Jun 17 '24 | Buy | $36.00 | 222,223 | $8,000,028.00 | 420,549 | SEC Form 4 |
| White William Richard | IRON | Director | Jun 3 '24 | Sell | $36.72 | 95 | $3,488.48 | 0 | SEC Form 4 |
| White William Richard | IRON | Director | Jun 3 '24 | Sell | $36.10 | 1,755 | $63,359.01 | 95 | SEC Form 4 |
| White William Richard | IRON | Director | Jun 3 '24 | Sell | $35.15 | 107 | $3,760.72 | 1,850 | SEC Form 4 |
| White William Richard | IRON | Director | May 1 '24 | Sell | $29.11 | 39 | $1,135.47 | 0 | SEC Form 4 |
| White William Richard | IRON | Director | May 1 '24 | Sell | $28.52 | 162 | $4,619.49 | 39 | SEC Form 4 |
| White William Richard | IRON | Director | Apr 11 '24 | Sell | $31.79 | 2,482 | $78,896.82 | 78 | SEC Form 4 |
| White William Richard | IRON | Director | Apr 11 '24 | Sell | $32.18 | 78 | $2,510.01 | 0 | SEC Form 4 |
| Bitterman Kevin | IRON | Director | Mar 5 '24 | Sell | $73.50 | 26,157 | $1,922,539.50 | 677,503 | SEC Form 4 |
| Bitterman Kevin | IRON | Director | Jan 23 '24 | Sell | $67.65 | 82,500 | $5,581,125.00 | 703,660 | SEC Form 4 |
| Bitterman Kevin | IRON | Director | Jan 23 '24 | Sell | $67.65 | 20,000 | $1,353,000.00 | 198,326 | SEC Form 4 |
| Atlas Venture Fund X, L.P. | IRON | 10% Owner | Jan 23 '24 | Sell | $67.65 | 47,500 | $3,213,375.00 | 1,402,186 | SEC Form 4 |
| Atlas Venture Fund X, L.P. | IRON | 10% Owner | Jan 23 '24 | Sell | $67.65 | 82,500 | $5,581,125.00 | 703,660 | SEC Form 4 |
| Atlas Venture Fund X, L.P. | IRON | 10% Owner | Jan 23 '24 | Sell | $67.65 | 20,000 | $1,353,000.00 | 198,326 | SEC Form 4 |
| Bitterman Kevin | IRON | Director | Jan 10 '24 | Sell | $64.00 | 20,000 | $1,280,000.00 | 786,160 | SEC Form 4 |
| Atlas Venture Fund X, L.P. | IRON | 10% Owner | Jan 10 '24 | Sell | $64.00 | 30,000 | $1,920,000.00 | 1,449,686 | SEC Form 4 |
Latest Disc Medicine Inc. News
IRON Breaking Stock News: Dive into IRON Ticker-Specific Updates for Smart Investing
Barrons.com
a month ago
Bitfarms Technologies, Vestis, and More Stocks See Action From Activist Investors
MT Newswires
a month ago
Disc Medicine Insider Bought Shares Worth $3,000,024, According to a Recent SEC Filing
MT Newswires
a month ago
BMO Capital Adjusts Price Target on Disc Medicine to $70 From $50, Maintains Outperform Rating
MT Newswires
a month ago
Wedbush Raises Disc Medicine Price Target to $57 From $43, Maintains Outperform Rating
MT Newswires
a month ago
Disc Medicine Prices $178 Million Common Stock Offering; Shares Rise
GlobeNewswire
a month ago
Disc Medicine Announces Underwritten Offering of Common Stock
GlobeNewswire
a month ago
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
Compare IRON vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRON Disc Medicine Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.